Phase 2 Ovarian Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have been diagnosed (confirmed by a lab test of tissue or cells) with a specific type of high-grade ovarian, fallopian tube, or primary peritoneal cancer.
• Your cancer has stopped responding to platinum-based chemotherapy (a common cancer treatment), meaning it either kept growing during treatment or came back within about 6 months of your last platinum treatment — or you have progressed after a second course of platinum-based treatment.
• You have received no more than 2 additional treatment regimens beyond platinum-based chemotherapy (note: maintenance therapies like PARP inhibitors or bevacizumab do not count as separate regimens).
• You are 18 years of age or older at the time of signing the consent form.
• Your cancer can be measured on a scan (according to a standard medical measurement system called RECIST 1.1).
• You are willing and able to give written consent to participate.
• You are generally able to carry out daily activities with little or no limitation (confirm with trial site).
• Your liver, kidneys, blood, lungs, and blood-clotting functions are all working well enough (confirm with trial site).

Who may not be able to join:

• You have received chemotherapy, a biologic treatment, an experimental treatment, or radiation therapy within the last 3 weeks before starting the trial drug.
• You are currently taking any other cancer treatment or experimental drug.
• You have another serious or significant ongoing illness or medical condition (confirm with trial site).
• You currently have an active HIV infection.
• You currently have an active hepatitis B or hepatitis C infection.

Important: Always verify eligibility with the trial site directly before applying.